Search research articles
Contact Us
Filters
Showing results (71-80 of 112) with videos related to
Page
of 12
Sort By:
Cancer Treatment Reports
|
November 1, 1987
Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study
W H Harvey, T R Fleming, G Beltran, et al.
Investigational New Drugs
|
November 1, 1991
A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin. A Southwest Oncology Group study
R P Whitehead, T R Fleming, J S Macdonald, et al.
Obstetrics and Gynecology
|
October 1, 1982
Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma
D G Decker, T R Fleming, G D Malkasian, et al.
Investigational New Drugs
|
February 1, 1993
Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma. Southwest Oncology Group study 8712
W H Harvey, T R Fleming, P J Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 1992
Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study
R M Bukowski, C Tangen, R Lee, et al.
Tumori
|
February 28, 1979
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung
R T Eagan, E T Creagan, J N Ingle, et al.
The New England Journal of Medicine
|
April 18, 1985
Trial of penicillamine in advanced primary biliary cirrhosis
E R Dickson, T R Fleming, R H Wiesner, et al.
Cancer Treatment Reports
|
March 1, 1981
Phase II evaluation of PALA in patients with metastatic lung cancer
E T Creagan, R T Eagan, T R Fleming, et al.
Anti-Cancer Drugs
|
June 1, 1992
High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancers
F M Muggia, T D Brown, P J Goodman, et al.
Cancer Treatment Reports
|
October 1, 1980
Phase II evaluation of triazinate in patients with metastatic lung cancer
E T Creagan, R T Eagan, T R Fleming, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 112) with videos related to
Sort By:
Page
of 12
Cancer Treatment Reports
|
November 1, 1987
Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study
W H Harvey, T R Fleming, G Beltran, et al.
Investigational New Drugs
|
November 1, 1991
A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin. A Southwest Oncology Group study
R P Whitehead, T R Fleming, J S Macdonald, et al.
Obstetrics and Gynecology
|
October 1, 1982
Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma
D G Decker, T R Fleming, G D Malkasian, et al.
Investigational New Drugs
|
February 1, 1993
Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma. Southwest Oncology Group study 8712
W H Harvey, T R Fleming, P J Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 1992
Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study
R M Bukowski, C Tangen, R Lee, et al.
Tumori
|
February 28, 1979
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung
R T Eagan, E T Creagan, J N Ingle, et al.
The New England Journal of Medicine
|
April 18, 1985
Trial of penicillamine in advanced primary biliary cirrhosis
E R Dickson, T R Fleming, R H Wiesner, et al.
Cancer Treatment Reports
|
March 1, 1981
Phase II evaluation of PALA in patients with metastatic lung cancer
E T Creagan, R T Eagan, T R Fleming, et al.
Anti-Cancer Drugs
|
June 1, 1992
High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancers
F M Muggia, T D Brown, P J Goodman, et al.
Cancer Treatment Reports
|
October 1, 1980
Phase II evaluation of triazinate in patients with metastatic lung cancer
E T Creagan, R T Eagan, T R Fleming, et al.
Page
of 12